Medtech Firms To See Significant User Fee Increases In FY 2020
Executive Summary
Most categories of medical device user fee applications will be 6% more expensive starting in October. Establishment registration fees will see more than a 7% increase as well, regardless of whether a company is considered a small business.
You may also be interested in...
Most Premarket Applications Will See 7% Increase Next Year
The US FDA has bumped up the cost of filing for a premarket application in fiscal year 2021 by roughly 7%. That’s slightly higher than the user fee increases under MDUFA IV last year.
Most FDA User Fees Will Increase By Almost 4% Next Fiscal Year
US FDA has released its 2019 device user-fee schedule, setting inflation-adjusted rates based on the MDUFA IV framework. Most applications regardless of company size will see a 3.9% increase. That's a far cry from the 32% user-fee increase for most application types in fiscal year 2018.
US FDA Fees To Spike In FY 2018, But Small Firms Get Breaks
The standard US FDA fee for a 510(k) submission will increase 124% in FY 2018, but small companies will see a much more moderate 12% jump. Other fees will increase by between 30%-40% in the coming fiscal year. And, perhaps, the biggest change will be for de novo submissions, which will have a user fee for the first time. FDA issued its inflation-adjusted user-fee schedule following the recent enactment of MDUFA IV.